We Design De Risk Dominate The New Standard in the
Pharma Industry
At Solvencis, the pharmaceutical landscape is recognised as a structured, dynamic, and precision-driven environment within the pharma industry. As a result, a Go-To-Market (GTM) strategy in this industry is shaped by the
coordinated management of clinical validation, market access, and supply chain excellence.
The Solvencis Edge: What Sets Our Delivery Apart
While many consultancies offer standard market entry frameworks, Solvencis provides a vertically integrated execution model for pharma industry companies. Rather than handing over slide decks, the firm builds execution-ready infrastructure that supports real delivery.
Concept to Clinic Frameworks
We help you conceptualise the value proposition of your molecule or device to ensure it resonates with both payers and providers.
Agile
Management
We oversee the entire GTM lifecycle, ensuring that marketing, sales, and supply chain teams are synchronised.
Custom Solver
Suites
Whether it’s a sudden regulatory shift or a competitor’s patent extension, we design bespoke tactical pivots to keep your launch on your success.
Beyond the Launch: Our Holistic Ecosystem
A successful GTM strategy begins long before the product hits the shelf and requires support long after the initial launch. Solvencis provides end to end lifecycle management.
Pre-GTM Readiness & Intelligence
Before you spend a dollar on commercialisation, we ensure the foundation is rock solid:
- Clinical Alignment: Bridging the gap between R&D results and commercial claims.
- Pricing & Reimbursement Models: Accordingly, designing models that satisfy health technology assessments (HTA) while simultaneously maintaining profitability.
- Regulatory Sandboxing: Simulating regulatory hurdles to stress test your submission strategy.
Contract Manufacturing (CMO) Support
Scaling production is often the biggest hurdle to a smooth GTM. We act as your technical liaison to:
Supply Chain De risking: Building redundancy into your manufacturing footprint to avoid stock outs.
- Supply Chain De risking: Building redundancy into your manufacturing footprint to avoid stock outs.
- Partner Selection: Identifying and auditing the right CMOs based on your specific dosage form and volume needs.
- Quality Oversight: Ensuring tech transfer processes meet global standards (FDA, EMA, etc.) to prevent launch delays.
Turnaround & Rescue Strategy
If a product is underperforming or a launch has stalled, Solvencis steps in to perform a GTM Audit
- Root Cause Analysis: First, identifying whether the failure stems from pricing, positioning, or, alternatively, distribution friction.
- Brand Revitalisation: Re conceptalising the product for a different patient segment or therapeutic indication.
- Operational Restructuring: Streamlining the sales force and marketing spend to maximise remaining patent life.
Strategy Focus
Traditional Consultancies:
Theoretical market mapping
The Solvencis Way
Execution ready roadmaps with localised regulatory pathways
Network
Traditional Consultancies:
General industry contacts.
The Solvencis Way
Deep rooted access to KOLs, hospital boards, and pharmacy chains.
Data Usage
Traditional Consultancies:
Historical market data.
The Solvencis Way
Predictive analytics on patient journeys and prescriber behavior.
Problem Solving
Traditional Consultancies:
Reactive troubleshooting
The Solvencis Way
Proactive bottleneck identification in the distribution cold chain.
Our Thought Leadership
We are a multidisciplinary team of industry professionals who have worked inside pharma, biotech, and healthcare organisations. This real-world experience allows us to deliver practical, execution-ready strategies not just recommendations.
Caleb Benjamin Masih
Executive Director
A Pharmaceutical, Healthcare and Biotech Industry leader with 25+ years of experience across general management, sales, marketing, and operations. He has led global and Indian organisations, driving product launches, P&L performance, and scalable growth across the full product lifecycle
FAQs
What makes Solvencis different from Big 4 or traditional strategy firms?
Traditional firms stop at ‘the what’ with high-level reports. Solvencis delivers the ‘how’ a hybrid consulting approach that combines boardroom strategy with on-ground execution, managing GTM rollout, vendors, manufacturing audits, and regulatory hurdles to ensure successful launches.
At what stage of the product lifecycle should we engage Solvencis?
While we add strong value during Pre-GTM (Phase II/III clinical trials), we are often engaged for turnaround strategies when products underperform post-launch or when launch fatigue demands a fresh, aggressive commercial approach.
Can you help with GTM in international or emerging markets?
Yes. We specialise in high-barrier markets like India, SE Asia, and Africa/Kenya, with deep expertise in local compliance, distributor networks, and special pass or permit requirements to deploy technical teams quickly
How does Solvencis support Contract Manufacturing (CMO) selection?
We don’t just share names. We conduct technical audits, assess Right First Time (RFT) performance, evaluate tech transfer capability, and act as your technical liaison to align CMO output with GTM timelines.
We already have a CMO how can you help us?
If manufacturing delays or quality spikes persist, we deliver operational turnaround by identifying bottlenecks raw materials, QC backlogs, or communication gaps and implementing a management framework to restore production timelines.
How do you handle regulatory or compliance hurdles mid-launch?
We treat regulatory hurdles as strategic variables, not administrative tasks identifying alternative pathways like revised labeling claims or specialised permits so one regulatory “no” doesn’t derail the project.
Do you work with startups or only established Big Pharma?
Our model serves both: for startups, we offer C-suite-as-a-service expertise they lack; for established firms, we act as an agile task force for complex, niche launches their teams are too stretched to handle.
The Solvencis Philosophy
We don’t just help you enter a market; we help you own it. By integrating manufacturing intelligence with commercial strategy, we turn pharmaceutical hurdles into competitive advantages.